Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in ADHD
IRCT138810193029N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of duloxetine in attention deficit hyperactivity disorder (ADHD), sponsored by Tehran University of Medical Sciences. Started Dec 2009; status: completed.
02
Drugs
duloxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT138810193029N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138810193029N1.